Trial
NCT02757417
Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University Hospitals Cleveland Medical Center
Collaborators
Megan Billow; Graham Chapman; Sangeeta Mahajan; Alex Soriano; Sherif El-Nashar
Condition
Ureteral Injury
Intervention
sodium fluorescein
Why stopped
Study never started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-06